KemPharm

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

You can watch KemPharm and buy or sell other stocks, ETFs, and their options commission-free!

About KMPH

Zevra Therapeutics, Inc. is a commercial-stage rare disease company that combines science, data and patient needs to create therapies for diseases with limited or no treatment options. The firm focuses on the treatment of rare neurological and sleep conditions such as certain Urea Cycle Disorders, Niemann Pick Disease Type C and Idiopathic Hypersomnia. 

CEO
Neil F. McFarlane
CEONeil F. McFarlane
Employees
59
Employees59
Headquarters
Celebration, Florida
HeadquartersCelebration, Florida
Founded
2006
Founded2006
Employees
59
Employees59

KMPH Key Statistics

Market cap
472.84M
Market cap472.84M
Price-Earnings ratio
-3.24
Price-Earnings ratio-3.24
Dividend yield
—
Dividend yield—
Average volume
488.76K
Average volume488.76K
High today
—
High today—
Low today
—
Low today—
Open price
—
Open price—
Volume
0.00
Volume0.00
52 Week high
$9.76
52 Week high$9.76
52 Week low
$4.20
52 Week low$4.20
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.